9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
[HTML][HTML] 2021 clinical practice guidelines for diabetes mellitus in Korea
Abstract The Committee of Clinical Practice Guidelines of the Korean Diabetes Association
(KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and …
(KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and …
Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study …
MJ Davies, VR Aroda, BS Collins, RA Gabbay… - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association and the European Association for the Study of Diabetes
convened a panel to update the previous consensus statements on the management of …
convened a panel to update the previous consensus statements on the management of …
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the …
Abstract The American Diabetes Association and the European Association for the Study of
Diabetes convened a panel to update the previous consensus statements on the …
Diabetes convened a panel to update the previous consensus statements on the …
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional … - Diabetes …, 2022 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
the ADA's current clinical practice recommendations and is intended to provide the …
the ADA's current clinical practice recommendations and is intended to provide the …
Body weight considerations in the management of type 2 diabetes
CM Apovian, J Okemah, PM O'Neil - Advances in therapy, 2019 - Springer
Obesity is one of the main risk factors for type 2 diabetes (T2D), representing a major
worldwide health crisis. Modest weight-loss (≥ 5% but< 10%) can minimize and reduce …
worldwide health crisis. Modest weight-loss (≥ 5% but< 10%) can minimize and reduce …
A review of GLP‐1 receptor agonists: evolution and advancement, through the lens of randomised controlled trials
VR Aroda - Diabetes, Obesity and Metabolism, 2018 - Wiley Online Library
Aims To review the evolution and advancement of GLP‐1 receptor agonist (GLP‐1RA)
therapy, through the lens of randomised controlled trials, from differentiating characteristics …
therapy, through the lens of randomised controlled trials, from differentiating characteristics …
Efficacy and safety of LixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes inadequately controlled on basal insulin and …
VR Aroda, J Rosenstock, C Wysham, J Unger… - Diabetes …, 2016 - Am Diabetes Assoc
OBJECTIVE This study was conducted to demonstrate the efficacy and safety of LixiLan
(iGlarLixi), a novel, titratable, fixed-ratio combination of insulin glargine (iGlar)(100 units) …
(iGlarLixi), a novel, titratable, fixed-ratio combination of insulin glargine (iGlar)(100 units) …
Analysis and reporting of adverse events in randomised controlled trials: a review
Objective To ascertain contemporary approaches to the collection, reporting and analysis of
adverse events (AEs) in randomised controlled trials (RCTs) with a primary efficacy …
adverse events (AEs) in randomised controlled trials (RCTs) with a primary efficacy …
Efficacy and safety of IDegLira versus basal-bolus insulin therapy in patients with type 2 diabetes uncontrolled on metformin and basal insulin: the DUAL VII …
LK Billings, A Doshi, D Gouet, A Oviedo… - Diabetes …, 2018 - Am Diabetes Assoc
OBJECTIVE In patients with uncontrolled type 2 diabetes on basal insulin, prandial insulin
may be initiated. We assessed the efficacy and safety of initiating insulin degludec/liraglutide …
may be initiated. We assessed the efficacy and safety of initiating insulin degludec/liraglutide …